Archive: Last Bill Status
- Passed Senate

You must fill out the form below in order
to support or oppose this bill. X

You must login or fill out the fields below for the senator to have an accurate account of the support or opposition to this bill.

First Name *

Last Name *

Email Address *

More information?

Street Address *

More information?

Apt/Suite/Floor (Optional)

City *

State *

Postal Code *

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

S6694 - Summary

Establishes a synthetic cannabinoid and substituted cathinone surrender program and relates to controlled substances.

S6694 - Sponsor Memo

BILL NUMBER:S6694
TITLE OF BILL:
An act
to establish a synthetic cannabinoid and substituted cathinone
surrender program; to amend the public health law and the penal law,
in relation to controlled substances; to repeal certain provisions of
the public health law, relating to controlled substances; and providing
for the repeal of certain provisions upon expiration thereof
PURPOSE:
To classify synthetic cannabinoids (the herb-like products that
contain synthetic cannabinoids often known as K2, Spike 99, Spice,
Yucatan Fire, Genie, Zohai and many others) and substituted
cathinones (these products, often referred to as "bath salts," are
chemically related to methamphetamines and ecstasy - which are both
classified as stimulants) as controlled substances under the public
health law and the penal law, and to create a Statewide Synthetic
Cannabinoid and Substituted Cathinone Amnesty and Surrender Program
to allow for surrender of these harmful substances to appropriate
authorities.
SUMMARY OF PROVISIONS:
Adds synthetic cannabinoids to the Controlled Substances Act (CSA) as
seven classes based on foundational chemical structures - which
should address the current practice of making minor alterations to

chemicals to subvert statutes that prohibit distinct substances.
Makes penalties for possession and sale similar to marijuana. These
substances are similar to marijuana in how they are used, the
neurochemical impact they illicit, and the quantities in which they
are sold.
Adds substituted cathinones to the CSA based on foundational chemical
structures - which should address the current practice of making
minor alterations to chemicals to subvert statutes that prohibit
distinct chemicals. A direct reference to "methcathinone" is removed
because it fits within the class. Makes penalties for possession and
sale similar to other stimulants, because these products often
referred to as "bath salts," are chemically related to
methamphetamines and ecstasy - which are both classified as stimulants.
Requires provisions to allow for the surrender of these substances
during the 90 day period after enactment of the law to the
appropriate authorities and requires that a database be maintained to
increase awareness of these products and their harmful effects.
EXISTING LAW:
Currently, these products are not prohibited under either the public
health law or the penal law, despite the harm to the individuals who
consume them and the public.
JUSTIFICATION:
Many recent news reports have brought to light the use of a legal
herb-like product that is laced with a synthetic cannabinoid that is
being smoked by individuals, including teens, as "fake weed," as well
as the substituted cathinones, known as "bath salts." While producing
a high similar to existing controlled substances, these legal
substances can have more dangerous side effects reported include
hallucinations, vomiting, agitation, increased heart rate, elevated
blood pressure and other adverse conditions. It presents a grave risk
to public health and safety to allow these to continue to be
available to the public.
These products can often be legally purchased in head shops, smoke
shops, tobacco shops or novelty shops. It can also be legally
purchased by mail or on the Internet. In fact, the product is often
marketed as incense or potpourri or bath salts.
Many states have already taken action against these substances,
including New Jersey and it is past time for New York to act as well.
LEGISLATIVE HISTORY:
New Bill.
FISCAL IMPLICATIONS:
None.
LOCAL FISCAL IMPLICATIONS:
None.
EFFECTIVE DATE:
90 days after it shall have become a law, with provisions.

S T A T E O F N E W Y O R K
________________________________________________________________________
6694
I N S E N A T E
March 9, 2012
___________
Introduced by Sens. FLANAGAN, LITTLE, GRIFFO -- read twice and ordered
printed, and when printed to be committed to the Committee on Health
AN ACT to establish a synthetic cannabinoid and substituted cathinone
surrender program; to amend the public health law and the penal law,
in relation to controlled substances; to repeal certain provisions of
the public health law, relating to controlled substances; and provid-
ing for the repeal of certain provisions upon expiration thereof
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. There is hereby established a statewide synthetic cannabi-
noid and substituted cathinone surrender program. Pursuant to this
program, for a period of ninety days commencing on the effective date of
this section:
The department of health shall establish a statewide synthetic canna-
binoid and substituted cathinone surrender program, in compliance with
federal law. The program shall be composed of locations throughout the
state, at which individuals may anonymously surrender products contain-
ing synthetic cannabinoids, as defined in section 3302 of the public
health law, and substituted cathinones, as defined in section 3306 of
the public health law. A surrender of synthetic cannabinoids and substi-
tuted cathinones pursuant to this section shall not constitute a "sale"
for the purposes of the penal law.
S 2. Subdivision 4 of section 3302 of the public health law, as added
by chapter 878 of the laws of 1972 and as renumbered by chapter 537 of
the laws of 1998, is amended to read as follows:
4. "Concentrated Cannabis" means
[(a)] the separated resin, whether crude or purified, obtained from a
plant of the genus Cannabis[; or
(b) a material, preparation, mixture, compound or other substance
which contains more than two and one-half percent by weight of delta-9
tetrahydrocannabinol, or its isomer, delta-8 dibenzopyran numbering
system, or delta-1 tetrahydrocannabinol or its isomer, delta 1 (6) mono-
terpene numbering system].
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14796-03-2

S. 6694 2
S 3. Subdivisions 33, 34, 35, 36, 37, 38, 39 and 40 of section 3302 of
the public health law are renumbered subdivisions 34, 35, 36, 37, 38,
39, 40 and 41 and a new subdivision 33 is added to read as follows:
33. "SYNTHETIC CANNABINOID" MEANS ANY MATERIAL, COMPOUND, MIXTURE OR
PREPARATION CONTAINING ANY QUANTITY OF:
(A) TETRAHYDROCANNABINOLS, NAPHTHOYLINDOLES, NAPHTHYLMETHYLINDOLES,
NAPHTHYLIDENEINDENES, PHENYLACETYLINDOLES, CYCLOHEXYLPHENOLS OR BENZOY-
LINDOLES, AS DEFINED IN SECTION THIRTY-THREE HUNDRED SIX OF THIS TITLE;
(B) (6AR, 10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,
7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210);
(C) (6AS, 10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-
6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211); OR
(D) 2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-Y1-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
S 4. Subdivision (d) of schedule I of section 3306 of the public
health law is amended by adding eleven new paragraphs 33, 34, 35, 36,
37, 38, 39, 40, 41, 42 and 43 to read as follows:
(33) NAPHTHOYLINDOLES. ANY COMPOUND CONTAINING A 3-(1-NAPHTHOYL)INDOLE
STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING BY
AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
(34) NAPHTHYLMETHYLINDOLES. ANY COMPOUND CONTAINING A
3-(1-NAPHTHOYL)INDOLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM
OF THE INDOLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL,
CYCLOALKYLETHYL, 1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)
ETHYL GROUP, WHETHER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO
ANY EXTENT AND WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY
EXTENT.
(35) NAPHTHYLMETHYLINDOLES. ANY COMPOUND CONTAINING A
H-INDOL-3-YL-(1-NAPHTHYL)METHANE STRUCTURE WITH SUBSTITUTION AT THE
NITROGEN ATOM OF THE INDOLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLO-
ALKYLMETHYL, CYCLOALKYLETHYL, 1-(N-METHYL-2-PIPERIDINYL)METHYL OR
2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT FURTHER SUBSTITUTED IN THE
INDOLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL
RING TO ANY EXTENT.
(36) NAPHTHOYLPYRROLES. ANY COMPOUND CONTAINING A
3-(1-NAPHTHOYL)PYRROLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM
OF THE PYRROLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL,
CYCLOALKYLETHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT FURTHER
SUBSTITUTED IN THE PYRROLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTI-
TUTED IN THE NAPHTHYL RING TO ANY EXTENT.
(37) NAPHTHYLIDENEINDENES. ANY COMPOUND CONTAINING A NAPHTHYLIDENEIN-
DENE STRUCTURE WITH SUBSTITUTION AT THE 3-POSITION OF THE INDENE RING BY
AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDENE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
(38) PHENYLACETYLINDOLES. ANY COMPOUND CONTAINING A 3-PHENYLACETYLIN-
DOLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING
BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
S. 6694 3
(39) CYCLOHEXYLPHENOLS. ANY COMPOUND CONTAINING A
2-(3-HYDROXYCYCLOHEXYL)PHENOL STRUCTURE WITH SUBSTITUTION AT THE 5-POSI-
TION OF THE PHENOLIC RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLME-
THYL, CYCLOALKYLETHYL, 1-(N-METHYL-2-PIPERIDINYL)METHYL OR
2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT SUBSTITUTED IN THE CYCLO-
HEXYL RING TO ANY EXTENT.
(40) BENZOYLINDOLES. ANY COMPOUND CONTAINING A 3-(BENZOYL)INDOLE
STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING BY
AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
(41) (6AR,10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210).
(42) (6AS,10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211).
(43) 2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-YL-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
S 5. Paragraph 5 of subdivision (f) of schedule I of section 3306 of
the public health law, as amended by chapter 457 of the laws of 2006, is
amended to read as follows:
(5) [Methcathinone (some other names: 2-(methylamino) - propiophenone;
alpha-(methylamino) propiophenone; 2-(methylamino) -1-phenylpropan-
1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone,
N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and UR1432),
its salts, optical isomers and salts of optical isomers] SUBSTITUTED
CATHINONES. ANY COMPOUND, OTHER THAN BUPROPRION, THAT IS STRUCTURALLY
DERIVED FROM 2-AMINO-1-PHENYL-1-PROPANONE BY MODIFICATION IN ANY OF THE
FOLLOWING WAYS:
(I) BY SUBSTITUTION IN THE PHENYL RING TO ANY EXTENT WITH ALKYL,
ALKOXY, ALKYLENEDIOXY, HALOALKYL, OR HALIDE SUBSTITUENTS, WHETHER OR NOT
FURTHER SUBSTITUTED IN THE PHENYL RING BY ONE OR MORE OTHER UNIVALENT
SUBSTITUENTS;
(II) BY SUBSTITUTION AT THE 3-POSITION WITH AN ALKYL SUBSTITUTENT;
(III) BY SUBSTITUTION AT THE NITROGEN ATOM WITH ALKYL OR DIALKYL
GROUPS, OR BY INCLUSION OF THE NITROGEN ATOM IN A CYCLIC STRUCTURE.
S 6. Paragraphs 9 and 10 of subdivision (f) of schedule I of section
3306 of the public health law are REPEALED.
S 7. Section 3308 of the public health law is amended by adding a new
subdivision 7 to read as follows:
7. THE COMMISSIONER SHALL, IN CONJUNCTION WITH THE DIVISION OF CRIMI-
NAL JUSTICE SERVICES, ESTABLISH AND MAINTAIN A DATABASE OF KNOWN
SYNTHETIC CANNABINOIDS, AS DEFINED IN SECTION THIRTY-THREE HUNDRED TWO
OF THIS TITLE, AND SUBSTITUTED CATHINONES, AS DEFINED IN SECTION THIR-
TY-THREE HUNDRED SIX OF THIS TITLE. THE DATABASE SHALL BE PUBLISHED ON
THE DEPARTMENT'S WEBSITE SO THAT CONSUMERS, RETAILERS, AND LAW ENFORCE-
MENT AGENCIES CAN ACCESS INFORMATION INCLUDING, BUT NOT LIMITED TO:
(A) A LIST OF COMPOUNDS KNOWN TO BELONG TO THE CLASSES OF CHEMICALS
LISTED ABOVE, AND THEIR TRADE NAMES;
(B) A PHYSICAL DESCRIPTION OF PRODUCTS KNOWN TO CONTAIN SUCH
COMPOUNDS, AND THEIR EFFECTS; AND
(C) A LIST OF THE BRAND NAMES OF PRODUCTS KNOWN TO CONTAIN SUCH
COMPOUNDS, AND IMAGES OF THEIR PACKAGING.
THE WEBSITE SHALL INCLUDE A STATEMENT INDICATING THAT SUCH INFORMATION
IS BEING PROVIDED AS A RESOURCE FOR CONSUMERS, RETAILERS, AND LAW
ENFORCEMENT; AND, DUE TO THE NATURE OF THE ILLEGAL DRUG TRADE, SUCH
S. 6694 4
INFORMATION MAY NOT BE COMPREHENSIVE. NEITHER THE DEPARTMENT NOR THE
DIVISION OF CRIMINAL JUSTICE SERVICES SHALL BE LIABLE FOR ANY ECONOMIC
HARM, PERSONAL INJURY, OR DEATH THAT MAY RESULT FROM INFORMATION
INCLUDED IN, OR OMITTED FROM, THE DATABASE.
S 8. Subdivisions 5, 6 and 10 of section 220.00 of the penal law,
subdivision 5 as amended by chapter 537 of the laws of 1998, subdivision
6 as amended by chapter 1051 of the laws of 1973 and subdivision 10 as
amended by chapter 664 of the laws of 1985, are amended to read as
follows:
5. "Controlled substance" means any substance listed in schedule I,
II, III, IV or V of section thirty-three hundred six of the public
health law other than marihuana, but including concentrated cannabis as
defined in [paragraph (a) of] subdivision four of section thirty-three
hundred two of such law.
6. "Marihuana" means "marihuana[" or]," "concentrated cannabis," OR
"SYNTHETIC CANNABINOID" as those terms are defined in section thirty-
three hundred two of the public health law.
10. "Hallucinogenic substance" means any controlled substance listed
in schedule I(d) other than concentrated cannabis, SYNTHETIC CANNABI-
NOIDS, lysergic acid diethylamide, or an hallucinogen.
S 9. Subdivision 4 of section 220.06 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
4. one or more preparations, compounds, mixtures or substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two of the public health law
and said preparations, compounds, mixtures or substances are of an
aggregate weight of one-fourth ounce or more; or
S 10. Subdivision 10 of section 220.09 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
10. one or more preparations, compounds, mixtures or substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two of the public health law
and said preparations, compounds, mixtures or substances are of an
aggregate weight of one ounce or more; or
S 11. Subdivision 3 of section 220.34 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
3. concentrated cannabis as defined in [paragraph (a) of] subdivision
four of section thirty-three hundred two of the public health law; or
S 12. This act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that the commissioner of health
and the division of criminal justice services shall immediately take the
actions necessary to ensure that the database created by subdivision 7
of section 3308 of the public health law, as added by section seven of
this act, and the surrender program established by section one of this
act, shall become operational on such effective date; and provided
further, that, notwithstanding the provisions of any law to the contra-
ry, for ninety days after this act shall have become law, section
220.03, 220.06, 220.09, 220.16, 220.18, 220.21, 221.10, 221.15, 221.20,
221.25 or 221.30 of the penal law shall not be enforced with regard to
the possession of synthetic cannabinoids, as defined in section 3302 of
the public health law, or substituted cathinones, as defined in section
3306 of the public health law, except that enforcement of such
provisions of penal law shall be allowed during this period with regard
to the possession of methacathinone, 4-methylmethcathinone, methylenedi-
oxypyrovalerone, and substances containing more than two and one-half
percent by weight of delta-9 tetrahydrocannabinol, or its isomer,
S. 6694 5
delta-8 dibenzopyran numbering system, or delta-1 tetrahydrocannabinol
or its isomer, delta 1(6) monoterpene numbering system; and provided,
further, that the provisions of section one of this act shall expire and
be deemed repealed on the ninety-first day after such effective date.

S6694A (ACTIVE) - Summary

Establishes a synthetic cannabinoid and substituted cathinone surrender program and relates to controlled substances.

S6694A (ACTIVE) - Sponsor Memo

BILL NUMBER:S6694A
TITLE OF BILL:
An act
to establish a synthetic cannabinoid and substituted cathinone
surrender program; to amend the public health law and the penal law,
in relation to controlled substances; to repeal certain provisions of
the public health law, relating to controlled substances; and providing
for the repeal of certain provisions upon expiration thereof
PURPOSE:
To classify synthetic cannabinoids (the herb-like products that
contain synthetic cannabinoids often known as K2, Spike 99, Spice,
Yucatan Fire, Genie, Zohai and many others) and substituted
cathinones (these products, often referred to as "bath salts," are
chemically related to methamphetamines and ecstasy - which are both
classified as stimulants) as controlled substances under the public
health law and the penal law, and to create a Statewide Synthetic
Cannabinoid and substituted Cathinone Surrender Program to allow for
surrender of these harmful substances to appropriate authorities.
SUMMARY OF PROVISIONS:
Adds nine classes of synthetic cannabinoids, based on foundational
chemical structures, to the controlled Substances Act (CSA)- which
should address the current practice of making minor alterations to
chemicals to subvert statutes that prohibit distinct substances.

Makes penalties for possession and sale similar to marijuana. These
substances are similar to marijuana in how they are used, the
neurochemical impact they illicit, and the quantities in which they
are sold.
Adds substituted cathinones to the CSA based on foundational chemical
structures - which should address the current practice of making
minor alterations to chemicals to subvert statutes that prohibit
distinct chemicals. A direct reference to "methcathinone" is removed
because it fits within the class. Makes penalties for possession and
sale similar to other stimulants, because these products often
referred to as "bath salts," are chemically related to
methamphetamines and ecstasy - which are both classified as stimulants.
Requires provisions to allow for the surrender of these substances
during the 90 day period after enactment of the law to the
appropriate authorities, and requires that a database be maintained
to increase awareness of these products and their harmful effects.
EXISTING LAW:
Currently, these products are not prohibited under either the public
health law or the penal law, despite the harm to the individuals who
consume them and the public.
JUSTIFICATION:
Many recent news reports have brought to light the use of a legal
herblike product that is laced with a synthetic cannabinoid that is
being
smoked by individuals, including teens, known as "fake weed"; as well
as the substituted cathinones, known as "bath salts." While producing
a high similar to existing controlled substances, these legal
substances can have more dangerous side effects, including
hallucinations, vomiting, agitation, increased heart rate, elevated
blood pressure and other adverse conditions.
Recognizing the health risks associated with use of synthetic
cannabiniods, the State Department of Health has issued an Order for
Summary Action ("Order") prohibiting the sale of substances belonging
to the classes of synthetic cannabiniods identified in this bill.
Citing increased calls to New York State Poison Control centers, and
federal action to prohibit the sale and possession of these dangerous
substances, the Order prohibits retailers from selling such products
- and could allow for the imposition of a fine or other civil penalty
against those who violate the Order.
This bill complements the measures taken under the direction of the
Governor by adding both synthetic cannabinoids, and the even more
dangerous substituted cathinones, to the CSA. Not only does this
provide for the imposition of criminal sanctions, but also makes it a
felony to sell such products to a minor or on school grounds.
Further, these actions would criminalize possession of such
substances - deterring use by law abiding individuals who may
otherwise be unaware of the harmful effects of these drugs.
LEGISLATIVE HISTORY:
New Bill.
FISCAL IMPLICATIONS:
None.
LOCAL FISCAL IMPLICATIONS:
None.
EFFECTIVE DATE:
90 days after it shall have become a law, with provisions.

S T A T E O F N E W Y O R K
________________________________________________________________________
6694--A
I N S E N A T E
March 9, 2012
___________
Introduced by Sens. FLANAGAN, LITTLE, GRIFFO, GOLDEN, KENNEDY, KLEIN,
RITCHIE, SALAND -- read twice and ordered printed, and when printed to
be committed to the Committee on Health -- reported favorably from
said committee and committed to the Committee on Codes -- committee
discharged, bill amended, ordered reprinted as amended and recommitted
to said committee
AN ACT to establish a synthetic cannabinoid and substituted cathinone
surrender program; to amend the public health law and the penal law,
in relation to controlled substances; to repeal certain provisions of
the public health law, relating to controlled substances; and provid-
ing for the repeal of certain provisions upon expiration thereof
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. There is hereby established a statewide synthetic cannabi-
noid and substituted cathinone surrender program. Pursuant to this
program, for a period of ninety days commencing on the effective date of
this section:
The department of health shall establish a statewide synthetic canna-
binoid and substituted cathinone surrender program, in compliance with
federal law. The program shall be composed of locations throughout the
state, at which individuals may anonymously surrender products contain-
ing synthetic cannabinoids, as defined in section 3302 of the public
health law, and substituted cathinones, as defined in section 3306 of
the public health law. A surrender of synthetic cannabinoids and substi-
tuted cathinones pursuant to this section shall not constitute a "sale"
for the purposes of the penal law.
S 2. Subdivision 4 of section 3302 of the public health law, as added
by chapter 878 of the laws of 1972 and as renumbered by chapter 537 of
the laws of 1998, is amended to read as follows:
4. "Concentrated Cannabis" means
[(a)] the separated resin, whether crude or purified, obtained from a
plant of the genus Cannabis[; or
(b) a material, preparation, mixture, compound or other substance
which contains more than two and one-half percent by weight of delta-9
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.

LBD14796-04-2
S. 6694--A 2
tetrahydrocannabinol, or its isomer, delta-8 dibenzopyran numbering
system, or delta-1 tetrahydrocannabinol or its isomer, delta 1 (6) mono-
terpene numbering system].
S 3. Subdivisions 33, 34, 35, 36, 37, 38, 39 and 40 of section 3302 of
the public health law are renumbered subdivisions 34, 35, 36, 37, 38,
39, 40 and 41 and a new subdivision 33 is added to read as follows:
33. "SYNTHETIC CANNABINOID" MEANS ANY MATERIAL, COMPOUND, MIXTURE OR
PREPARATION CONTAINING ANY QUANTITY OF:
(A) TETRAHYDROCANNABINOLS, NAPHTHOYLINDOLES, NAPHTHYLMETHYLINDOLES,
NAPHTHOYLPYRROLES, NAPHTHYLIDENEINDENES, PHENYLACETYLINDOLES, CYCLOHEX-
YLPHENOLS, BENZOYLINDOLES, OR ADAMANTOYLINDOLES, AS DEFINED IN SECTION
THIRTY-THREE HUNDRED SIX OF THIS TITLE;
(B) (6AR, 10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-
6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210);
(C) (6AS, 10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-
6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211); OR
(D) 2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-Y1-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
S 4. Subdivision (d) of schedule I of section 3306 of the public
health law is amended by adding eleven new paragraphs 33, 34, 35, 36,
37, 38, 39, 40, 41, 42 and 43 to read as follows:
(33) NAPHTHOYLINDOLES. ANY COMPOUND CONTAINING A 3-(1-NAPHTHOYL)INDOLE
STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING BY
AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
(34) NAPHTHYLMETHYLINDOLES. ANY COMPOUND CONTAINING A
H-INDOL-3-YL-(1-NAPHTHYL)METHANE STRUCTURE WITH SUBSTITUTION AT THE
NITROGEN ATOM OF THE INDOLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLO-
ALKYLMETHYL, CYCLOALKYLETHYL, 1-(N-METHYL-2-PIPERIDINYL)METHYL OR
2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT FURTHER SUBSTITUTED IN THE
INDOLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL
RING TO ANY EXTENT.
(35) NAPHTHOYLPYRROLES. ANY COMPOUND CONTAINING A
3-(1-NAPHTHOYL)PYRROLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM
OF THE PYRROLE RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL,
CYCLOALKYLETHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT FURTHER
SUBSTITUTED IN THE PYRROLE RING TO ANY EXTENT AND WHETHER OR NOT SUBSTI-
TUTED IN THE NAPHTHYL RING TO ANY EXTENT.
(36) NAPHTHYLIDENEINDENES. ANY COMPOUND CONTAINING A NAPHTHYLIDENEIN-
DENE STRUCTURE WITH SUBSTITUTION AT THE 3-POSITION OF THE INDENE RING BY
AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDENE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE NAPHTHYL RING TO ANY EXTENT.
(37) PHENYLACETYLINDOLES. ANY COMPOUND CONTAINING A 3-PHENYLACETYLIN-
DOLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING
BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
(38) CYCLOHEXYLPHENOLS. ANY COMPOUND CONTAINING A
2-(3-HYDROXYCYCLOHEXYL)PHENOL STRUCTURE WITH SUBSTITUTION AT THE 5-POSI-
TION OF THE PHENOLIC RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLME-
THYL, CYCLOALKYLETHYL, 1-(N-METHYL-2-PIPERIDINYL)METHYL OR
S. 6694--A 3
2-(4-MORPHOLINYL)ETHYL GROUP, WHETHER OR NOT SUBSTITUTED IN THE CYCLO-
HEXYL RING TO ANY EXTENT.
(39) BENZOYLINDOLES. ANY COMPOUND CONTAINING A 3-(BENZOYL)INDOLE
STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE RING BY
AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERIDINYL)METHYL OR 2-(4-MORPHOLINYL)ETHYL GROUP, WHETH-
ER OR NOT FURTHER SUBSTITUTED IN THE INDOLE RING TO ANY EXTENT AND
WHETHER OR NOT SUBSTITUTED IN THE PHENYL RING TO ANY EXTENT.
(40) ADAMANTOYLINDOLES. ANY COMPOUND CONTAINING A 3-(1-ADAMANTOYL)
INDOLE STRUCTURE WITH SUBSTITUTION AT THE NITROGEN ATOM OF THE INDOLE
RING BY AN ALKYL, HALOALKYL, ALKENYL, CYCLOALKYLMETHYL, CYCLOALKYLETHYL,
1-(N-METHYL-2-PIPERINDINYL)METHYL, OR 2-(4-MORPHOLINYL)ETHYL GROUP,
WHETHER OR NOT FURTHER SUBSTITUTED IN THE ADAMANTYL RING SYSTEM TO ANY
EXTENT.
(41) (6AR,10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (HU-210).
(42) (6AS,10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)
-6A,7,10,10A-TETRAHYDROBENZO{C}CHROMEN-1-OL (DEXANABINOL OR HU-211).
(43) 2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO{1,2,3-DE}-1,
4-BENZOXAZIN-6-YL-1-NAPHTHALENYLMETHANONE (WIN 55,212-2).
S 5. Paragraph 5 of subdivision (f) of schedule I of section 3306 of
the public health law, as amended by chapter 457 of the laws of 2006, is
amended to read as follows:
(5) [Methcathinone (some other names: 2-(methylamino) - propiophenone;
alpha-(methylamino) propiophenone; 2-(methylamino) -1-phenylpropan-
1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone,
N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and UR1432),
its salts, optical isomers and salts of optical isomers] SUBSTITUTED
CATHINONES. ANY COMPOUND, OTHER THAN BUPROPRION, THAT IS STRUCTURALLY
DERIVED FROM 2-AMINO-1-PHENYL-1-PROPANONE BY MODIFICATION IN ANY OF THE
FOLLOWING WAYS:
(I) BY SUBSTITUTION IN THE PHENYL RING TO ANY EXTENT WITH ALKYL,
ALKOXY, ALKYLENEDIOXY, HALOALKYL, OR HALIDE SUBSTITUENTS, WHETHER OR NOT
FURTHER SUBSTITUTED IN THE PHENYL RING BY ONE OR MORE OTHER UNIVALENT
SUBSTITUENTS;
(II) BY SUBSTITUTION AT THE 3-POSITION WITH AN ALKYL SUBSTITUTENT;
(III) BY SUBSTITUTION AT THE NITROGEN ATOM WITH ALKYL OR DIALKYL
GROUPS, OR BY INCLUSION OF THE NITROGEN ATOM IN A CYCLIC STRUCTURE.
S 6. Paragraphs 9 and 10 of subdivision (f) of schedule I of section
3306 of the public health law are REPEALED.
S 7. Section 3308 of the public health law is amended by adding a new
subdivision 7 to read as follows:
7. THE COMMISSIONER SHALL, IN CONJUNCTION WITH THE DIVISION OF CRIMI-
NAL JUSTICE SERVICES, ESTABLISH AND MAINTAIN A DATABASE OF KNOWN
SYNTHETIC CANNABINOIDS, AS DEFINED IN SECTION THIRTY-THREE HUNDRED TWO
OF THIS TITLE, AND SUBSTITUTED CATHINONES, AS DEFINED IN SECTION THIR-
TY-THREE HUNDRED SIX OF THIS TITLE. THE DATABASE SHALL BE PUBLISHED ON
THE DEPARTMENT'S WEBSITE SO THAT CONSUMERS, RETAILERS, AND LAW ENFORCE-
MENT AGENCIES CAN ACCESS INFORMATION INCLUDING, BUT NOT LIMITED TO:
(A) A LIST OF COMPOUNDS KNOWN TO BELONG TO THE CLASSES OF CHEMICALS
LISTED ABOVE, AND THEIR TRADE NAMES;
(B) A PHYSICAL DESCRIPTION OF PRODUCTS KNOWN TO CONTAIN SUCH
COMPOUNDS, AND THEIR EFFECTS; AND
(C) A LIST OF THE BRAND NAMES OF PRODUCTS KNOWN TO CONTAIN SUCH
COMPOUNDS, AND IMAGES OF THEIR PACKAGING.
S. 6694--A 4
THE WEBSITE SHALL INCLUDE A STATEMENT INDICATING THAT SUCH INFORMATION
IS BEING PROVIDED AS A RESOURCE FOR CONSUMERS, RETAILERS, AND LAW
ENFORCEMENT; AND, DUE TO THE NATURE OF THE ILLEGAL DRUG TRADE, SUCH
INFORMATION MAY NOT BE COMPREHENSIVE. NEITHER THE DEPARTMENT NOR THE
DIVISION OF CRIMINAL JUSTICE SERVICES SHALL BE LIABLE FOR ANY ECONOMIC
HARM, PERSONAL INJURY, OR DEATH THAT MAY RESULT FROM INFORMATION
INCLUDED IN, OR OMITTED FROM, THE DATABASE.
S 8. Subdivisions 5, 6 and 10 of section 220.00 of the penal law,
subdivision 5 as amended by chapter 537 of the laws of 1998, subdivision
6 as amended by chapter 1051 of the laws of 1973 and subdivision 10 as
amended by chapter 664 of the laws of 1985, are amended to read as
follows:
5. "Controlled substance" means any substance listed in schedule I,
II, III, IV or V of section thirty-three hundred six of the public
health law other than marihuana, but including concentrated cannabis as
defined in [paragraph (a) of] subdivision four, AND SYNTHETIC CANNABI-
NOID AS DEFINED IN SUBDIVISION THIRTY-THREE, of section thirty-three
hundred two of such law.
6. "Marihuana" means "marihuana[" or]," "concentrated cannabis," OR
"SYNTHETIC CANNABINOID" as those terms are defined in section thirty-
three hundred two of the public health law.
10. "Hallucinogenic substance" means any controlled substance listed
in schedule I(d) other than concentrated cannabis, SYNTHETIC CANNABI-
NOIDS, lysergic acid diethylamide, or an hallucinogen.
S 9. Subdivision 4 of section 220.06 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
4. one or more preparations, compounds, mixtures or substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two of the public health
law, OR SYNTHETIC CANNABINOID AS DEFINED IN SUBDIVISION THIRTY-THREE OF
SECTION THIRTY-THREE HUNDRED TWO OF THE PUBLIC HEALTH LAW, and said
preparations, compounds, mixtures or substances are of an aggregate
weight of one-fourth ounce or more; or
S 10. Subdivision 10 of section 220.09 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
10. one or more preparations, compounds, mixtures or substances
containing concentrated cannabis as defined in [paragraph (a) of] subdi-
vision four of section thirty-three hundred two of the public health
law, OR SYNTHETIC CANNABINOID AS DEFINED IN SUBDIVISION THIRTY-THREE OF
SECTION THIRTY-THREE HUNDRED TWO OF THE PUBLIC HEALTH LAW, and said
preparations, compounds, mixtures or substances are of an aggregate
weight of one ounce or more; or
S 11. Subdivision 3 of section 220.34 of the penal law, as amended by
chapter 537 of the laws of 1998, is amended to read as follows:
3. concentrated cannabis as defined in [paragraph (a) of] subdivision
four of section thirty-three hundred two of the public health law, OR
SYNTHETIC CANNABINOID AS DEFINED IN SUBDIVISION THIRTY-THREE OF SECTION
THIRTY-THREE HUNDRED TWO OF THE PUBLIC HEALTH LAW; or
S 12. This act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that the commissioner of health
and the division of criminal justice services shall immediately take the
actions necessary to ensure that the database created by subdivision 7
of section 3308 of the public health law, as added by section seven of
this act, and the surrender program established by section one of this
act, shall become operational on or before such effective date; and
provided further, that, notwithstanding the provisions of any law to the
S. 6694--A 5
contrary, for ninety days after this act shall have become law, section
220.03, 220.06, 220.09, 220.16, 220.18, 220.21, 221.05, 221.10, 221.15,
221.20, 221.25 or 221.30 of the penal law shall not be enforced with
regard to the possession of synthetic cannabinoids, as defined in
section 3302 of the public health law, or substituted cathinones, as
defined in section 3306 of the public health law, except that enforce-
ment of such provisions of the penal law shall be allowed during this
period with regard to the possession of methacathinone, 4-methylmeth-
cathinone, methylenedioxypyrovalerone, and substances containing more
than two and one-half percent by weight of delta-9 tetrahydrocannabinol,
or its isomer, delta-8 dibenzopyran numbering system, or delta-1 tetrah-
ydrocannabinol or its isomer, delta 1(6) monoterpene numbering system;
and provided, further, that the provisions of section one of this act
shall expire and be deemed repealed on the ninety-first day after such
effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.